Midkine and Prostate Cancer
Author Information
Author(s): You Zongbing, Dong Ying, Kong Xiangtian, Beckett Laurel A, Gandour-Edwards Regina, Melamed Jonathan
Primary Institution: University of California, Davis
Hypothesis
Midkine expression is induced by certain growth factors and cytokines, particularly TNFα, in prostate cancer cells.
Conclusion
Midkine expression is significantly increased in late stage prostate cancer, suggesting its role in cancer progression.
Supporting Evidence
- Midkine expression was significantly higher in late stage prostate cancers compared to early stage cancers and normal tissues.
- TNFα was identified as the strongest inducer of midkine expression in prostate cancer cell lines.
- Knockdown of midkine expression enhanced TNFα-induced apoptosis in LNCaP cells.
Takeaway
Midkine is a protein that helps prostate cancer cells survive, especially when they are exposed to certain signals like TNFα.
Methodology
The study involved cell line experiments, Western blot analysis, real-time quantitative RT-PCR, and immunohistochemical staining of prostate tissue microarrays.
Potential Biases
Potential bias in the selection of tissue samples and the interpretation of immunohistochemical staining.
Limitations
The study primarily focused on in vitro experiments, which may not fully represent in vivo conditions.
Participant Demographics
The study analyzed 129 prostate tissue samples, including 18 normal tissues, 40 early stage cancers, and 71 late stage cancers.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website